# The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus

> **NCT01608724** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 2165 (actual)

## Conditions studied

- Diabetes Mellitus, Non-Insulin-Dependent

## Interventions

- **DRUG:** Saxagliptin

## Key facts

- **NCT ID:** NCT01608724
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 2165 (ACTUAL)
- **Last updated:** 2016-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01608724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01608724, "The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01608724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*